Aurobindo Pharma Limited (BOM:524804)
1,192.90
+11.70 (0.99%)
At close: Jan 1, 2026
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
11.74M INR
Profits / Employee
1.24M INR
Market Cap
692.90B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Aurobindo Pharma News
- 9 days ago - Aurobindo Pharma to acquire additional 20% stake in China JV Luoxin Aurovitas for $5.1 million - Business Upturn
- 15 days ago - Aurobindo Pharma receives Form 483 with five observations after US FDA inspection at Unit-IV facility - Business Upturn
- 20 days ago - Aurobindo Pharma’s subsidiary receives US FDA Form 483 with three procedural observations after Telangana facility inspection - Business Upturn
- 4 weeks ago - JSW Steel, Kotak Mahindra & more: Top stocks to buy today — Check list - The Times of India
- 7 weeks ago - Aurobindo Pharma receives US FDA clearance for Unit-I; Warning letter officially closed - Business Upturn
- 2 months ago - [Brokerage calls] Top stocks to watch on November 7: Cummins, UPL, Lupin, Aurobindo Pharma among key brokerage picks - Business Upturn
- 2 months ago - Aurobindo Pharma Ltd (BOM:524804) Q2 2026 Earnings Call Highlights: Strong European Growth and ... - GuruFocus
- 2 months ago - Q2 2026 Aurobindo Pharma Ltd Earnings Call Transcript - GuruFocus